Tafmate 25 Tablet 30's
₹1323*
MRP ₹1470
10% off
₹1249*
MRP ₹1470
15% CB
₹221 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Tafmate 25 Tablet belongs to the group of medicines known as ‘antiviral medicines’ used to control HIV infection and chronic hepatitis B infection. Human immunodeficiency virus (HIV) is a sexually transmitted infection that over time leads to acquired immunodeficiency syndrome (AIDS). Chronic hepatitis B is a long-term viral infection caused by the hepatitis B virus.
Tafmate 25 Tablet contains ‘Tenofovir disoproxil fumarate’ which is an antiviral/HIV medicine and works by prevents the development of the virus in human cells. This prevents the virus from producing new viruses and cleans up your infection. It can effectively reduce the symptoms associated with HIV and chronic hepatitis B infection.
Take Tafmate 25 Tablet as prescribed by your doctor. Your doctor will recommend how often you take Tafmate 25 Tablet based on your medical condition. Some people may experience diarrhea, rash, nausea, pain, weakness, and stomach pain. Most of these side effects of Tafmate 25 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Tafmate 25 Tablet should not be taken if you are allergic to Tafmate 25 Tablet or any other contents present in it. Patients should take necessary precautions to avoid infecting others. This medicine should not be given to adolescents with a history of kidney failure. If you have liver disease including hepatitis B or C, then you should not take this Tafmate 25 Tablet . Inform your doctor if you are pregnant, planning to become pregnant, and breastfeeding. Avoid drinking alcohol as it may increase the risk of side effects. It is advisable to avoid driving while using Tafmate 25 Tablet as Tafmate 25 Tablet may cause dizziness that may affect the ability to drive or use machines. Tafmate 25 Tablet should not be used for children less than 12 years of age.
Tafmate 25 Tablet belongs to the group of medications called ‘antiretroviral drugs’ used to control HIV infection and chronic hepatitis B. Tafmate 25 Tablet decreases the amount of HIV in your body. Therefore, your immune system may work better. This reduces your chance of getting complications of HIV like new infections, cancer and enhances your quality of life. Tafmate 25 Tablet works by prevents the development of viruses in human cells. This prevents the virus from producing new viruses and cleans up your infection. It can effectively reduce the symptoms associated with HIV and chronic hepatitis B infection.
Tafmate 25 Tablet should not be taken if you are allergic to Tafmate 25 Tablet or any other contents present in it. Tafmate 25 Tablet should not be taken in the conditions like liver disease, bone problems kidney disease. This medicine should not be given to adolescents with a history of kidney failure. Tafmate 25 Tablet does not decrease the chances of passing infections to others. Inform your doctor before taking Tafmate 25 Tablet if you observe any symptoms of infection or other symptoms like weakness beginning in the hands and feet, muscle weakness and moving up towards the trunk of the body, palpitations (racing or skipping heartbeat), hyperactivity and tremor. Patients should take necessary precautions to avoid infecting others. Inform your doctor if you are pregnant, planning to become pregnant and breastfeeding. Inform your doctor before using Tafmate 25 Tablet if you are older than 65 years of age. Avoid drinking alcohol as it may increase the risk of side effects. It is advisable to you do not drive while using Tafmate 25 Tablet as Tafmate 25 Tablet may cause dizziness that may affect the ability to drive or use machines. Tafmate 25 Tablet should not be used for children less than 12 years of age.
Drug-Drug Interactions: Tafmate 25 Tablet may interact with an antibiotic (gentamycin, tobramycin, pentamidine, vancomycin), antifungal medicines (amphotericin B), antiviral disease (foscarnet, ganciclovir, or cidofovir), anticancer (interleukin-2), medicines used to treat hepatitis B virus (adefovir dipivoxil), pain killer (ibuprofen).
Drug-Food Interactions: Avoid grapefruit juice and drinking alcohol.
Drug-Disease Interactions: Tafmate 25 Tablet should be used with caution in patients with bone disease, severe liver, or kidney diseases.
Your doctor may regularly monitor liver function, kidney function, and bone density if you take Tafmate 25 Tablet .
Human immunodeficiency syndrome (HIV): It is a virus that suppresses the immune system and causes acquired immunodeficiency syndrome (AIDS) over time. The suppression of immunity leads to the development of opportunistic infections. It is a life-long condition, and there is no permanent cure. The treatment (antiretroviral therapy) is given to suppress the infection.
Chronic Hepatitis B: It is a severe and long-term liver infection caused by the hepatitis B virus (HBV). It spreads by contact with infected body fluids. The symptoms of this condition are abdominal pain, dark urine, and yellowing of the eyes.
Alcohol
Caution
Avoid drinking alcohol. Consuming alcohol while using Tafmate 25 Tablet may worsen the condition.
Pregnancy
Caution
Tafmate 25 Tablet is a category B medicine. It should be used with caution in pregnant women because it may cause side effects to the unborn baby.
Breast Feeding
Unsafe
The active part of Tafmate 25 Tablet may pass with breast milk. Women who are HIV-positive must not breast-feed, because HIV infection can be passed on to the baby in breast milk.
Driving
Caution
Tafmate 25 Tablet may cause dizziness. So, avoid driving or refrain from any activities that require you to alert mentally.
Liver
Caution
Tafmate 25 Tablet should be used with caution in patients with liver diseases. Dose adjustments may be necessary. Patients with liver disease, who are treated with Tafmate 25 Tablet , have a higher risk of serious and possibly fatal liver complications.
Kidney
Unsafe
Tafmate 25 Tablet should not be used in adolescents with kidney disease. In other people with severe kidney diseases, Tafmate 25 Tablet is given only if clinically needed.
Children
Unsafe
Tafmate 25 Tablet should not be used in children below 12 years of age.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes